PUBLIC COMPANY

$FBRXForte Biosciences, Inc.

Dallas, TX, USupdated 1mo ago

SEC EDGAR Yahoo Finance

community read0 votes

pipeline

1

marketed

0

phase 3

0

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(1)

pipeline depth1 products

1Phase 2

Phase 2

FB-102

Celiac Disease

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Forte Biosciences, Inc. jobs →

News

no news has mentioned this company yet

$FBRX

Insider activity

source: SEC Form 4

routine RSU / option mechanics (6)

Apr 1, 26tax coverRiley Antony A · CHIEF FINANCIAL OFFICER134 sh
Apr 1, 26tax coverWagner Paul A. · SEE REMARKS98 sh
Apr 1, 26option exerciseRiley Antony A · CHIEF FINANCIAL OFFICER375 sh
Apr 1, 26option exerciseRiley Antony A · CHIEF FINANCIAL OFFICER375 sh
Apr 1, 26option exerciseWagner Paul A. · SEE REMARKS1,250 sh
Apr 1, 26option exerciseWagner Paul A. · SEE REMARKS1,250 sh

Data sources

SEC EDGAR

last refreshed 51m ago

Found something off?

Active trials

phase1A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.recruitingn=32
phase1A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligorecruitingn=64
phase2Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celiac Diseaserecruitingn=100

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?